EN
HI
Summary
As of 30 Aug, 2026, Goldline Pharmaceutical stock price is ₹41. During the trading session, the stock has moved between an intraday low of ₹40.14 and an intraday high of ₹41.00. Over the last 52 weeks, Goldline Pharmaceutical has traded between ₹33.00 and ₹60.00.
The stock has recorded a trading volume of 78,000 shares, with a market capitalization of ₹9600000. Its Average Traded Price (ATP) is ₹40.96, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 75000 @ ₹41.00.
Goldline Pharmaceutical has an upper circuit limit of ₹49.16 and a lower circuit limit of ₹32.78. The total value traded stands at ₹31.95 L, and the delivery percentage for the day is -1%.
The stock is currently traded with a market lot size of 3000. Goldline Pharmaceutical also offers a dividend yield of 0%.
Goldline Pharmaceutical share price chart
Goldline Pharmaceutical Share Key Metrics
Volume
78000.00
Market Cap
39.33 CR
LTQ@LTP
75000@41.00
ATP
40.96
Var Margin
53.5 %
Circuit Range
32.78-49.16
Delivery %
- %
Value
31.95 L
ASM/GSM
No
Market Lot
3000
Goldline Pharmaceutical Fundamentals
P/E Ratio
0
P/B Ratio
0
Div. Yield
0
Sector P/E
64.49
Sector P/B
-0.01
Sec. Div. Yield
75.39
Goldline Pharmaceutical Resistance and Support
Pivot 40.14
Resistance
First Resistance
40.14
Second Resistance
40.14
Third Resistance
40.14
Support
First Support
40.14
Second Support
40.14
Third Support
40.14
Goldline Pharmaceutical Historical Data
| Day | Open | Close | Change(%) | Day High | Day Low |
|---|---|---|---|---|---|
| Fri Aug 28 2026 | 40.14 | 41 | 2.17% | 41 | 40.14 |
| Wed Aug 26 2026 | 40.13 | 40.13 | 0.00% | 40.13 | 40.13 |
| Tue Aug 25 2026 | 40.45 | 40.13 | 3.16% | 40.45 | 39 |
Goldline Pharmaceutical Corporate Actions
| Date | Agenda |
|---|---|
| 2026-06-09 | Audited Results |
Goldline Pharmaceutical News
Goldline Pharmaceutical Ltd - 544759 - Intimation Of Record Date For Remote E-Voting
Goldline Pharmaceutical set August 22, 2026, as the record date for remote e-voting for its 22nd AGM. E-voting opens August 25 and closes August 28, 2026.
Aug 06 2026 19:24:41
Goldline Pharmaceutical Management
| Name | Position |
|---|---|
| Amol Laxmikant Mujumdar | Chairman & Managing Director |
| Swapan Premprakash Khandelwal | Whole Time Director |
Goldline Pharmaceutical Similar Stocks
Goldline Pharmaceutical FAQs
The Buying Price of Goldline Pharmaceutical share is 41 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Goldline Pharmaceutical stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Goldline Pharmaceutical, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Goldline Pharmaceutical shares is 0. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Goldline Pharmaceutical shares is 0. Useful to assess the stock's value relative to its book value.
To assess Goldline Pharmaceutical’s valuation compare Sector P/E, P/B which are 64.49 & -0.01 with sector averages, along with growth rates and financial metrics.
The Market Cap of Goldline Pharmaceutical is 39.33 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Goldline Pharmaceutical share price is 60.00 & 33.00. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Goldline Pharmaceutical belongs to the Healthcare sector.
Open Your Free
Demat Account Now!
AMC for First Year- Auto Square Off Charges
13 Lakh+ Clients
Expert-Backed
Premium Tools
Open Your Free
Demat Account Now!
- AMC For First Year
- Account Opening Fee
- 13 Lakh+ Clients
- Expert-Backed
- Premium Tools
